文献速递瓣膜病与结构性心脏病血脂与心血管预防

1型与2型糖尿病患者左侧退行性瓣膜病风险研究

Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes.
PubMed 文献 · Circulation · 2022-06-09

结果显示1型和2型糖尿病患者瓣膜狭窄风险增加,而2型糖尿病瓣膜反流风险较低;即使心血管危险因素控制良好,瓣膜狭窄风险仍持续升高。

要点

  • 1型和2型糖尿病均与主动脉瓣狭窄和二尖瓣狭窄风险增加相关。
  • 2型糖尿病患者主动脉瓣反流和二尖瓣反流风险较低。
  • 危险因素达标者瓣膜狭窄风险仍高于对照,无明确阶梯下降。

核心结论

  • 1型和2型糖尿病患者瓣膜狭窄风险增加,2型糖尿病瓣膜反流风险较低。
  • 即使心血管危险因素接近目标范围,瓣膜狭窄风险仍持续存在。

研究设计与样本

  • 采用发病率与Cox回归分析趋势,并评估糖尿病作为危险因素的作用。

主要发现

  • 糖尿病患者和一般人群中瓣膜结局发生率均呈上升趋势。
  • 2型糖尿病中,收缩压、体重指数和肾功能与瓣膜病变相关。
  • 2型糖尿病危险因素接近达标者与对照相比,主动脉瓣狭窄HR 1.34(95%CI 1.31-1.38),主动脉瓣反流HR 0.67(95%CI 0.64-0.70),二尖瓣狭窄HR 1.95(95%CI 1.76-2.20),二尖瓣反流HR 0.82(95%CI 0.79-0.85)。
  • 1型糖尿病危险因素接近最佳控制者与对照相比,主动脉瓣狭窄HR 2.01(95%CI 1.58-2.56),主动脉瓣反流HR 0.63(95%CI 0.43-0.94),二尖瓣狭窄HR 3.47(95%CI 1.37-8.84)。
  • 2型糖尿病狭窄病变超额风险:主动脉瓣狭窄HR 1.62(95%CI 1.59-1.65),二尖瓣狭窄HR 2.28(95%CI 2.08-2.50);1型糖尿病分别为HR 2.59(95%CI 2.21-3.05)和HR 11.43(95%CI 6.18-21.15)。

临床怎么用

  • 对1型和2型糖尿病患者应关注瓣膜狭窄的筛查与监测。
  • 2型糖尿病患者瓣膜反流风险较低,但仍需结合临床评估。
  • 危险因素控制良好不能完全消除瓣膜狭窄风险,需持续警惕。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of diabetes in the development of valvular heart disease, and, in particular, the relation with risk factor control, has not been extensively studied. METHODS: We included 715 143 patients with diabetes registered in the Swedish National Diabetes Register and compared them with 2 732 333 matched controls randomly selected from the general population. First, trends were analyzed with incidence rates and Cox regression, which was also used to assess diabetes as a risk factor compared with controls, and, second, separately in patients with diabetes according to the presence of 5 risk factors. RESULTS: The incidence of valvular outcomes is increasing among patients with diabetes and the general population. In type 2 diabetes, systolic blood pressure, body mass index, and renal function were associated with valvular lesions. Hazard ratios for patients with type 2 diabetes who had nearly all risk factors within target ranges, compared with controls, were as follows: aortic stenosis 1.34 (95% CI, 1.31-1.38), aortic regurgitation 0.67 (95% CI, 0.64-0.70), mitral stenosis 1.95 (95% CI, 1.76-2.20), and mitral regurgitation 0.82 (95% CI, 0.79-0.85). Hazard ratios for patients with type 1 diabetes and nearly optimal risk factor control were as follows: aortic stenosis 2.01 (95% CI, 1.58-2.56), aortic regurgitation 0.63 (95% CI, 0.43-0.94), and mitral stenosis 3.47 (95% CI, 1.37-8.84). Excess risk in patients with type 2 diabetes for stenotic lesions showed hazard ratios for aortic stenosis 1.62 (95% CI, 1.59-1.65), mitral stenosis 2.28 (95% CI, 2.08-2.50), and excess risk in patients with type 1 diabetes showed hazard ratios of 2.59 (95% CI, 2.21-3.05) and 11.43 (95% CI, 6.18-21.15), respectively. Risk for aortic and mitral regurgitation was lower in type 2 diabetes: 0.81 (95% CI, 0.78-0.84) and 0.95 (95% CI, 0.92-0.98), respectively. CONCLUSIONS: Individuals with type 1 and 2 diabetes have greater risk for stenotic lesions, whereas risk for valvular regurgitation was lower in patients with type 2 diabetes. Patients with well-controlled cardiovascular risk factors continued to display higher risk for valvular stenosis, without a clear stepwise decrease in risk between various degrees of risk factor control.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Rawshani A, Sattar N, McGuire DK, et al. Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes. Circulation. 2022. PMID: 35678729. doi:10.1161/CIRCULATIONAHA.121.058072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。